PIK3CA Mutation H1047R Is Associated with Response to PI3K/AKT/mTOR Signaling Pathway Inhibitors in Early-Phase Clinical Trials

✍ Scribed by Janku, F.; Wheler, J. J.; Naing, A.; Falchook, G. S.; Hong, D. S.; Stepanek, V. M.; Fu, S.; Piha-Paul, S. A.; Lee, J. J.; Luthra, R.; Tsimberidou, A. M.; Kurzrock, R.

• Book ID: 118272086
• Publisher: American Association for Cancer Research
• Year: 2012
• Tongue: English
• Weight: 494 KB
• Volume: 73
• Category: Article
• ISSN: 0008-5472
• DOI: 10.1158/0008-5472.can-12-1726